Victory Capital Management’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Buy |
15,397
+235
| +2% | +$195 | ﹤0.01% | 2466 |
|
|
2025
Q1 | $10.2K | Sell |
15,162
-393
| -3% | -$264 | ﹤0.01% | 2452 |
|
|
2024
Q4 | $14.7K | Sell |
15,555
-401
| -3% | -$379 | ﹤0.01% | 2460 |
|
|
2024
Q3 | $24.3K | Sell |
15,956
-244
| -2% | -$371 | ﹤0.01% | 2430 |
|
|
2024
Q2 | $19.3K | Buy |
+16,200
| New | +$19.3K | ﹤0.01% | 2434 |
|
|
2023
Q4 | – | Sell |
-13,823
| Closed | -$10.2K | – | 2541 |
|
|
2023
Q3 | $10.2K | Sell |
13,823
-42
| -0.3% | -$31 | ﹤0.01% | 2485 |
|
|
2023
Q2 | $17.5K | Sell |
13,865
-321
| -2% | -$404 | ﹤0.01% | 2457 |
|
|
2023
Q1 | $10.3K | Sell |
14,186
-185
| -1% | -$134 | ﹤0.01% | 2547 |
|
|
2022
Q4 | $7.6K | Sell |
14,371
-5
| -0% | -$3 | ﹤0.01% | 2555 |
|
|
2022
Q3 | $12K | Sell |
14,376
-1,278
| -8% | -$1.07K | ﹤0.01% | 2648 |
|
|
2022
Q2 | $17K | Sell |
15,654
-107
| -0.7% | -$116 | ﹤0.01% | 2628 |
|
|
2022
Q1 | $16K | Sell |
15,761
-1,554
| -9% | -$1.58K | ﹤0.01% | 2650 |
|
|
2021
Q4 | $28K | Sell |
17,315
-539
| -3% | -$872 | ﹤0.01% | 2672 |
|
|
2021
Q3 | $58K | Sell |
17,854
-614
| -3% | -$2K | ﹤0.01% | 2676 |
|
|
2021
Q2 | $117K | Buy |
18,468
+7,421
| +67% | +$47K | ﹤0.01% | 2583 |
|
|
2021
Q1 | $23K | Buy |
+11,047
| New | +$23K | ﹤0.01% | 2713 |
|
|
2020
Q2 | – | Sell |
-3,100
| Closed | -$4K | – | 2568 |
|
|
2020
Q1 | $4K | Buy |
+3,100
| New | +$4K | ﹤0.01% | 3509 |
|
|
2019
Q4 | – | Sell |
-1,642
| Closed | -$3K | – | 2686 |
|
|
2019
Q3 | $3K | Buy |
+1,642
| New | +$3K | ﹤0.01% | 3545 |
|